Skip to main content

ISOQOL

Events
  • Live Events
  • On Demand Events
Upcoming Events
On-Demand Events
Courses
Webinar Series
Search
Cart 0
Sign In

Item Added to Cart

You just added

You have item(s) in your cart

  • Proceed to Checkout

Measuring What Matters 2021

7 Presentations 0 Sections

Intensive longitudinal measurement:
Methodologies for collecting, analyzing and interpreting patient-generated data from daily diaries, wearables and sensors


As we collect data more frequently in both clinical and real-world studies, patients are often assessed using intensive longitudinal measurement techniques, such as daily diaries, wearable devices, and/or sensor technology. This allows the recording of data at regular intervals between site visits, the capture of acute events as they occur for clinical monitoring, and/or continuous monitoring in order to answer research questions that were previously unanswerable through traditional data collection.

Despite our ability to collect more data, our knowledge about evaluating new data collection techniques and using these rich data sources effectively is limited.

This symposium will cover

  • patient-centered approaches to endpoint selection/development
  • the subsequent identification of appropriate methods and technology for assessing these endpoints
  • the different ways we currently summarize this data and how this leads to a loss of information
  • ways to maximise our data using improved summary methods and more complex modelling techniques
Attendees will leave this symposium with new insights and better understanding on how to better use, analyze, and interpret intensive longitudinal data generated from daily diary and wearable devices in a more effective and complementary manner.

Symposium Committee Co-Chairs

            
Pip Griffiths, PhD
IQVIA
France
                   
Jiat Ling Poon, PhD
Eli Lilly and Company
United States
     
R.J. Wirth, PhD
Vector Psychometric Group, LLC
United States

Sponsored by:
 
 


ISOQOL members receive a discounted rate. To view membership rates, click  here.

$150.00 - $350.00
Member
$250.00
Non-Member
$350.00
Member: Student/Special/Retired
$150.00
Patient Research Partner: Regular
$250.00
Patient Research Partner: Affiliate
$250.00
Member: Honorary
$250.00
Items Included in the Purchase of this Event

Session I: Intensive longitudinal measurement and you: How do you measure what matters?

Presentation: Elizabeth (Nicki) Bush, MHS, Eli Lilly and Company, Indianapolis, Indiana, United States, Elektra Papadopoulos, MD MPH, U.S. Food and Drug Administration, Silver Spring, Maryland, United States, Jennifer Goldsack, MChem MA MBA, Digital Medicine Society (DiMe), Boston, Massachusetts, United States, 67 min 38 sec

Session II: Walking a mile in the patient’s shoes

Presentation: Bray Patrick-Lake, MFS, Evidation Health, Erie, Colorado, United States, W. Benjamin Nowell, PhD MSW, Global Healthy Living Foundation, New York, New York, United States, 60 min 2 sec

Session III: Having your cake and eating it, too: Mixing modalities to enhance interpretation of data

Presentation: Sonya Eremenco, MA, Critical Path Institute, Tucson, Arizona, United States, Jay Trudeau, PhD, Janssen Global Services, LLC, Raritan, New Jersey, United States, 60 min 30 sec

Session IV: Why did the researcher throw away their data? - How to handle intensive longitudinal data as a research outcome

Presentation: Carrie Houts, PhD, Vector Psychometric Group, Tempe, Arizona, United States, Don Hedeker, PhD, University of Chicago, Chicago, Illinois, United States, Willie Muehlhausen, Safira Clinical Research, Dublin, Ireland, 72 min 26 sec

Session V: What makes a step a step? A step by any other algorithm…

Presentation: Brinnae Bent, PhD, Edge Analytics, Durham, North Carolina, United States, Ieuan Clay, PhD, Evidation Health, Munich, Germany, Ilya Lipkovich, Eli Lilly, Indianapolis, Indiana, United States, 73 min 52 sec

Session VI: When good science meets good standards - Regulatory considerations around intensive longitudinal data

Presentation: Andrew Potter, PhD, U.S. Food and Drug Administration, Silver Spring, Maryland, United States, Jennifer Goldsack, MChem MA MBA, Digital Medicine Society (DiMe), Boston, Massachusetts, United States, 61 min 14 sec

Session VII: A World of Pure Imagination: The evolving landscape and undefined future

Presentation: Sonya Eremenco, MA, Critical Path Institute, Tucson, Arizona, United States, R.J. Wirth, PhD, Vector Psychometric Group, LLC, Chapel Hill, North Carolina, United States, Elektra Papadopoulos, MD MPH, U.S. Food and Drug Administration, Silver Spring, Maryland, United States, 63 min 2 sec
  • ISOQOL
  • Events
  • Courses
  • Search
  • Support
  • Sign In
  • Privacy Policy | Cookies Policy